Conference abstract · 2022
Case reportPublished 18 May 2023
Malignancy Harder to Treat or Cure Cancer
Department of Medicine, Duke University Medical Center, Durham, USA
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
The prediction of response to chemotherapy at the molecular level is currently mostly based on data derived from in vitro experiments. Besides studies in patient populations and xenograft models of tumors, cell cultures are the most commonly used in vitro systems for the analysis of cellular responses to drug treatment.
Keywords
Subjects
Oncology & CancerAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
Similar by topic
Conference abstract · 2020
Personalized and Precision Medicine as a Unique Avenue to have the Healthcare Model Renewed to Secure the National Biosafety: To Get Cancer Treated or Cured?
Editorial · 6 Jun 2016
Integrated Cancer Therapy: Treat the Person to Cure the Cancer
Review article · 2015
Evidence that Human Prostate Cancer is a ZIP1-Deficient Malignancy that could be Effectively Treated with a Zinc Ionophore (Clioquinol) Approach
Perspective · 30 Oct 2024
From Normal to Malignant the Cellular Pathways Driving Cancer Development
More from this journal
The newest in Advances in Cancer Prevention.
Editorial · 29 Dec 2025
Prostate Cancer Prevention: Lifestyle, Chemoprevention, Detection, and Future
Editorial · 29 Dec 2025
Lung Cancer Prevention: A Multi-Pronged Strategy
Editorial · 29 Dec 2025
Oral Cancer Prevention: Detection, Risk Factors, And Access
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalAdvances in Cancer Prevention
- SubjectOncology & Cancer
- BylineArticles whose byline prints “Hongyu Tian”
